Latest Industry Insights
Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin
A new study has compared the effects of varied doses of psilocybin and LSD for the first time. These two popular psychedelics have been of increasing interest in clinical research. Technology Networks caught up with Rob Barrow, CEO of MindMed, to discuss the findings in more detail and explore pressing issues around blinding in psychedelic drug development.
Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future
Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Driving Forward Huntington’s Disease Research
Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
Exploring How VR Could Be Used in Psychedelic-Assisted Psychotherapy
Psychedelic-assisted psychotherapy (PAP) is under investigation for its potential in treating psychiatric conditions. A recent paper, published by academics Agnieszka Sekula and Dr. Prash Puspanathan, outlined how virtual reality (VR) might be incorporated into aspects of the PAP process.
Live Biotherapeutics ‒ A Novel Way To Treat Disease
The intricate and intertwined nature of the host‒microbiota connection has garnered increasing interest from the scientific community in recent years, due to its known role in the development and progression of various diseases. 4D pharma has leveraged growing knowledge in the field, by creating a novel class of medicines called live biotherapeutic products (LBPs).
Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors
Technology Networks spoke to Renee Ryan, Cala Health's CEO, to learn more about bioelectronic medicine and its use as a therapy for essential tremors.
How Restoring Brain Plasticity Is the Secret to Reversing Brain Damage
For the world’s leading neuroscientists, unlocking the brain’s capacity to stimulate neural plasticity has become something of a Holy Grail. In this Insight, NervGen Pharma president and CEO Paul Brennan details why plasticity is so important for the brain.
Using Bioelectronic Assays To Advance Drug Discovery for Neurological Diseases
In this interview, Jim Ross highlights several recent examples of how bioelectronic assays are helping to advance drug discovery for neurological diseases ranging from pediatric epilepsy to Burning Man Syndrome.
When We Become Leaders, How Do We Lead Science Towards Gender Equity?
Emulate's chief scientific officer, Dr. Lorna Ewart, talks about inspiring a new generation of women in STEM.
CRACKing the Brain’s Cellular Code: An Interview With Professor Jerry Chen
Unpicking our brain's complexity at a cellular level is a mammoth task. How do our genes, cells and electrical impulses come together to decode the world around us? At Boston University Assistant Professor Jerry Chen is trying to crack this code. In this interview, we speak to Chen about his study’s aims, findings and implications.